Integrating Radiotherapy With Epidermal Growth Factor Receptor Antagonists and Other Molecular Therapeutics for the Treatment of Head and Neck Cancer
- 15 November 2007
- journal article
- review article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 69 (4), 974-984
- https://doi.org/10.1016/j.ijrobp.2007.06.076
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysisThe Lancet, 2006
- Signaling through ERBB receptors: Multiple layers of diversity and controlCellular Signalling, 2006
- Selecting Lung Cancer Patients for Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors by Immunohistochemistry and FluorescenceIn situHybridization—Why, When, and How?Clinical Cancer Research, 2006
- Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinomaEuropean Journal of Cancer, 2006
- Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathwayCancer Cell, 2005
- Structural basis for inhibition of the epidermal growth factor receptor by cetuximabCancer Cell, 2005
- Phosphotyrosine interactome of the ErbB‐receptor kinase familyMolecular Systems Biology, 2005
- ZD6474, a Potent Inhibitor of Vascular Endothelial Growth Factor Signaling, Combined With RadiotherapyClinical Cancer Research, 2004
- The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- The stimulation of epidermal proliferation by a specific protein (EGF)Developmental Biology, 1965